Fadi El Karak

Beirut, BA, Lebanon

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Impact of Lack of Access to Immunotherapy on Survival in Stage IV Non-Small Cell Lung Cancer: A Multicenter Retrospective Study From Lebanon.

Impact of Lack of Access to Immunotherapy on Survival in Stage IV Non-Small Cell Lung Cancer: A Multicenter Retrospective Study From Lebanon.

Journal: JCO global oncology

Published: July 22, 2026

Characterization of cytogenetic abnormalities in Lebanese multiple myeloma patients.

Characterization of cytogenetic abnormalities in Lebanese multiple myeloma patients.

Journal: BMC cancer

Published: July 10, 2025

Delphi for management of N2 non-small cell lung cancer.

Delphi for management of N2 non-small cell lung cancer.

Journal: Surgical oncology

Published: November 19, 2024

Pharmacotherapy developments in autophagy inhibitors for bladder cancer.

Pharmacotherapy developments in autophagy inhibitors for bladder cancer.

Journal: Expert opinion on pharmacotherapy

Published: September 05, 2023

Consensus Recommendations for the Diagnosis, Biomarker Testing, and Clinical Management of Advanced or Metastatic Non-small Cell Lung Cancer With Mesenchymal-Epithelial Transition Exon 14 Skipping Mutations in the Middle East, Africa, and Russia.

Consensus Recommendations for the Diagnosis, Biomarker Testing, and Clinical Management of Advanced or Metastatic Non-small Cell Lung Cancer With Mesenchymal-Epithelial Transition Exon 14 Skipping Mutations in the Middle East, Africa, and Russia.

Journal: Cureus

Published: July 16, 2023

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC).

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC).

Journal: Oncotarget

Published: May 26, 2023

Diagnosis and management of patients with stage III non‑small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese Pulmonary Society (Review).

Diagnosis and management of patients with stage III non‑small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese Pulmonary Society (Review).

Journal: Oncology letters

Published: August 02, 2022

Management of breast cancer patients with BRCA gene mutations in Lebanon of the Middle East: perspectives and challenges.

Management of breast cancer patients with BRCA gene mutations in Lebanon of the Middle East: perspectives and challenges.

Journal: Hospital practice (1995)

Published: September 22, 2021

Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study.

Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study.

Journal: BMC cancer

Published: March 03, 2021

Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients.

Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients.

Journal: Journal of oncology

Published: June 22, 2020

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer.

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer.

Journal: Cancer medicine

Published: May 13, 2020

Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer.

Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer.

Journal: The Gulf journal of oncology

Published: May 03, 2020

Showing 1-12 of 40

Last Updated: 09/26/2026